| Molecular formula | C33H57N11O9 |
| Molecular weight | 751.9 g/mol |
| Registered trials | 10 |
| PubChem CID | 11765600 |
What Selank Is
Selank is a synthetic peptide with the molecular formula C33H57N11O9 and a molecular weight of about 751.9 (PubChem CID 11765600). It has no FDA-approved label, no approved brand name, and no authorized medical use in the United States. Any use outside of registered research settings falls outside its current regulatory status.
Trial Footprint
Across public registries, 10 clinical trials reference this compound or related research areas. One identified study, NCT05411185, examined acute high altitude hypoxia and its effects on cognitive function in lowlanders and is listed as completed. Beyond this, the available trial sample does not provide further detail specific to Selank, and no phase designation should be inferred from the overall count.
FAQ
No. Selank has no FDA-approved label, no approved brand name, and no authorized medical indication. It is classified as an investigational compound used only in research contexts.
Selank is a synthetic peptide with the molecular formula C33H57N11O9 and a molecular weight of approximately 751.9. Its chemical identity is catalogued under PubChem CID 11765600.
Public registries list 10 clinical trials associated with this compound or its research area. One identified study looked at cognitive function during acute high altitude hypoxia exposure and has been completed.
No adverse event report data is currently available for this compound in the data reviewed. This means no side effect pattern can be summarized at this time.
Because Selank lacks an approved label, no approved uses, benefits, or administration guidance can be stated. Any application remains confined to research settings.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-08-03